Clinical Trials Browser

Neoplasms × Antineoplastic Agents × 1 year × Clear all

NCT07621289 2026-06-02

EUCARTOXSCORES

Not yet recruiting

10,000 enrolled

Other hematologic neoplasm

Cardiovascular Diseases, Neoplasms, Hematologic Neoplasms

NCT06877533 2025-08-12

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

Phase 1 Terminated

Neoplasm Metastasis, Neoplasms